Mounjaro (tirzepatide) is an innovative injectable medication approved for the management of type 2 diabetes and widely used off-label for weight management. As a dual GIP and GLP-1 receptor agonist, Mounjaro works by enhancing insulin secretion, reducing appetite, slowing gastric emptying, and improving metabolic control. To ensure safety, tolerability, and long-term treatment...